SCHEMBL4630330

SCHEMBL4630330

Nc1ccc(Oc2cccc(N3CCCCC3)c2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.59
▸ MAPT P10636 4/20 0.59
▸ MEN1 O00255 4/20 0.59
▸ KMT2A Q03164 4/20 0.59
▸ SMN1; SMN2 Q16637 3/20 0.59
▸ GAA P10253 3/20 0.59
▸ MITF O75030 1/20 0.59
▸ GFER P55789 1/20 0.59
▸ NLRP1 Q9C000 1/20 0.59
▸ NOD2 Q9HC29 1/20 0.59
▸ NPC1 O15118 2/20 0.53
▸ RAB9A P51151 2/20 0.53
▸ ALOX15 P16050 2/20 0.53
▸ HTT P42858 2/20 0.53
▸ L3MBTL1 Q9Y468 2/20 0.53
▸ KDM4E B2RXH2 1/20 0.53
▸ USP2 O75604 1/20 0.53
▸ TP53 P04637 1/20 0.53
▸ POLB P06746 1/20 0.53
▸ THRB P10828 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30228382 0.86 SLC6A2 (0.51) ALDH1A1MAPTMEN1KMT2AGAA
SCHEMBL11510734 0.84 SLC6A2 (0.52) ALDH1A1MAPTMEN1KMT2AGAA
SCHEMBL16621272 0.84 ALDH1A1 (0.56) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL4630328 0.81 PARP10 (0.65) ALDH1A1MEN1KMT2AGAAKDM4E
SCHEMBL4631009 0.81 ALDH1A1 (0.47) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL22944451 0.79 ADRB1 (0.51) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL2399483 0.79 AGXT (0.44) ALDH1A1MAPTMEN1KMT2AGAA
SCHEMBL15928733 0.79 ADRA2C (0.66) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL30469317 0.79 ADRA2C (0.66) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL1397693 0.79 ADRA2C (0.66) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919875-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS Astex Therapeutics Limited (GB) 2008-05-14 — — EP disclosed
WO-2006136829-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS ASTEX THERAPEUTICS LIMITED (GB) 2006-12-28 — — WO disclosed
Send feedback